92 related articles for article (PubMed ID: 761226)
1. Sensitivity of human granulopoiesis in vitro to adriamycin before and after exposure in vivo.
Lohrmann HP; Schreml W
Cancer Res; 1979 Feb; 39(2 Pt 1):527-30. PubMed ID: 761226
[TBL] [Abstract][Full Text] [Related]
2. Effect of high-dose methotrexate with citrovorum factor on human granulopoiesis.
Schremi W; Lohrmann HP
Cancer Res; 1979 Oct; 39(10):4195-9. PubMed ID: 314330
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of adriamycin and daunorubicin for normal and leukemia progenitor cells of man.
Buick RN; Messner HA; Till JE; McCulloch EA
J Natl Cancer Inst; 1979 Feb; 62(2):249-55. PubMed ID: 310906
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic effects of 1-beta-D-arabinofuranosylcytosine and 6-thioguanine in vitro on granulocytic progenitor cells.
Greenberg PL; VanKersen I; Mosny S
Cancer Res; 1976 Dec; 36(12):4412-7. PubMed ID: 1069606
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the sensitivities of human, canine, and murine hematopoietic precursor cells to adriamycin and N-trifluoroacetyladriamycin-14-valerate.
Marsh JC
Cancer Res; 1979 Feb; 39(2 Pt 1):360-4. PubMed ID: 761207
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin toxicity in relation to the proliferative state of human hematopoietic cells.
Minderman H; Linssen PC; Wessels JM; Haanen C
Exp Hematol; 1991 Feb; 19(2):110-4. PubMed ID: 1991492
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
8. Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factor.
Hestdal K; Jacobsen SE; Ruscetti FW; Longo DL; Boone TC; Keller JR
Exp Hematol; 1993 Jun; 21(6):799-805. PubMed ID: 8500577
[TBL] [Abstract][Full Text] [Related]
9. Changes of granulopoiesis during and after adjuvant chemotherapy of breast cancer.
Lohrmann HP; Schreml W; Lang M; Betzler M; Fliedner TM; Heimpel H
Br J Haematol; 1978 Nov; 40(3):369-81. PubMed ID: 749923
[TBL] [Abstract][Full Text] [Related]
10. The in vitro and in vivo effects of stem cell factor on human hematopoiesis.
Hoffman R; Tong J; Brandt J; Traycoff C; Bruno E; McGuire BW; Gordon MS; McNiece I; Srour EF
Stem Cells; 1993 Jul; 11 Suppl 2():76-82. PubMed ID: 7691331
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone.
Merchav S; Tatarsky I; Hochberg Z
J Clin Invest; 1988 Mar; 81(3):791-7. PubMed ID: 2963830
[TBL] [Abstract][Full Text] [Related]
12. Alterations in the growth and cycling status of granulocyte-monocyte colony-forming units (CFU-GM) in rats injected single doses of aflatoxin B1.
Cukrová V; Kurita N; Akao M
Neoplasma; 1992; 39(2):93-6. PubMed ID: 1528314
[TBL] [Abstract][Full Text] [Related]
13. Granulopoietic effects of lithium on human bone marrow in vitro.
Richman CM; Kinnealey A; Hoffman PC
Exp Hematol; 1981 Apr; 9(4):449-55. PubMed ID: 6972319
[TBL] [Abstract][Full Text] [Related]
14. Methods for measuring suppression of hematopoiesis.
Chervenick PA
Exp Hematol; 1985; 13 Suppl 16():8-15. PubMed ID: 3987838
[TBL] [Abstract][Full Text] [Related]
15. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
[TBL] [Abstract][Full Text] [Related]
16. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
Valtieri M; Tocci A; Gabbianelli M; Luchetti L; Masella B; Vitelli L; Botta R; Testa U; Condorelli GL; Peschle C
Cancer Res; 1998 Feb; 58(3):562-9. PubMed ID: 9458106
[TBL] [Abstract][Full Text] [Related]
17. Reaction of human granulopoiesis to high-dose cyclophosphamide therapy.
Lohrmann HP; Schreml W; Fliedner TM; Heimpel H
Blut; 1979 Jan; 38(1):9-16. PubMed ID: 758963
[TBL] [Abstract][Full Text] [Related]
18. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
19. Use of liquid culture and cell cycle analysis to compare drug damage following in vitro treatment of normal human bone marrow cells with adriamycin, arabinosyl-cytosine, and etoposide.
Cavazzana M; Calvo F; Facchin P; Barreau P; Geny B; Dal Cortivo L; Dresch C
Exp Hematol; 1988 Nov; 16(10):876-83. PubMed ID: 3169155
[TBL] [Abstract][Full Text] [Related]
20. [Antibiotics and hematopoiesis: toxicity of beta-lactam on in vitro granulopoiesis].
Marie JP
Pathol Biol (Paris); 1987 Dec; 35(10 Pt 2):1408-11. PubMed ID: 3325906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
